Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors-Reference-Cited by-全球学者库

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors

Published:2024-01 Issue:1 Volume:14 Page:87-109
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Song Letian,Gao Shenghua,Ye Bing,Yang Mianling,Cheng Yusen,Kang Dongwei,Yi Fan,Sun Jin-Peng,Menéndez-Arias Luis^ORCID,Neyts Johan,Liu Xinyong^ORCID,Zhan Peng^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference148 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

2. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat Rev Microbiol,2021

3. World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int/.

4. SARS-CoV-2 variants of concern;Choi;Yonsei Med J,2021

5. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift;Cameroni;Nature,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration;Bioorganic & Medicinal Chemistry;2023-12

2. Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability;Journal of Medicinal Chemistry;2023-11-22

3. Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives;Biomolecules;2023-09-02